Nucleic acid immunization
OwnerConnie S. Schmaljohn, James T. Fullerinventors
Life of this patent
Estimating the term…
Abstract
Recombinant nucleic acid molecules are described. The molecules have a sequence or sequences encoding an antigen from Bacillus anthracis. Vectors and compositions containing these molecules are also described. Methods for eliciting an immune response using these molecules and compositions are also described.
Claims56
A polynucleotide vaccine composition comprising a nucleic acid sequence that encodes a Bacillus anthracis antigen, wherein said nucleic acid sequence is operatively linked to a promoter suitable for expression of the antigen in a mammalian cell.
A polynucleotide vaccine composition, said composition comprising:
- a first nucleic acid sequence that encodes a Bacillus anthracis antigen;
- and a second nucleic acid sequence that encodes a leader signal peptide operatively linked to the first nucleic acid sequence, wherein said first and said second nucleic acid sequences are operatively linked to a promoter suitable for expression thereof in a mammalian cell and said leader signal peptide provides for the secretion of the encoded antigen.
A method for using a Bacillus anthracis antigen to induce a protective immune response in a subject, said method comprising:
- (a) providing an expression cassette containing a nucleic acid sequence encoding the Protective Antigen from Bacillus anthracis operatively linked to control sequences that direct expression of the Protective Antigen when introduced into tissue of the subject;
- and
- (b) administering the expression cassette to tissue of the subject such that the Protective Antigen is expressed in an amount sufficient to induce said protective immune response in the subject.
A method for using a Bacillus anthracis antigen to induce an immune response in a subject, said method comprising:
- (a) providing an expression cassette containing a first nucleic acid sequence encoding the Protective Antigen from Bacillus anthracis and a second nucleic acid sequence that encodes a leader signal peptide, wherein said first and second nucleic acid sequences are operatively linked to each other and to control sequences that direct expression of said sequences when introduced into tissue of the subject and said leader signal peptide provides for the secretion of the encoded Protective Antigen;
- and
- (b) administering the expression cassette to tissue of the subject such that the Protective Antigen is expressed in an amount sufficient to induce said immune response in the subject.
Dependencies are inferred from the claim text.